AGENEBIO
AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company is headquartered in Indianapolis but conducts research and development work on a global basis utilizing partner relationships.
AGENEBIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.agenebio.com
Total Employee:
1+
Status:
Active
Contact:
(410) 685-3000
Email Addresses:
[email protected]
Total Funding:
14.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - AgeneBio
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - AgeneBio
National Institutes of Health
National Institutes of Health investment in Grant - AgeneBio
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - AgeneBio
National Institute on Aging
National Institute on Aging investment in Grant - AgeneBio
Sahsen Ventures
Sahsen Ventures investment in Venture Round - AgeneBio
Official Site Inspections
http://www.agenebio.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
